Skip to content

Effect of Laghu-vaishvanar Churna and Dhanya Nagar kwath in management of Sublinical Hypothyroidism

A Randomized Comparative Clinical Study To Evaluate The Efficacy of Laghuvaishvanarchurna And *Dhanyanagarkwath In The Management Of Dhatvagnimandhya wsr To Subclinical Hypothyroidism

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041744
Enrollment
60
Registered
2022-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

None listed

Sponsors

Ayurvedic and Unani Tibbia College Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient willing to participate in the trial and sign the consent form. 2. The patients between the age group of 18 to 60 years in either sex. 3. Patients of subclinical hypothyroidism with features mentioned in subjective parameters. 4. On the basis of raised serum TSH(5-10 μIU/ml) and normal serum T4 level.

Exclusion criteria

Exclusion criteria: 1. Patients who were not willing for trial. 2. TSH level more than 10 or less than 5 μIU/ml. 3. Patient with presenting sign of moderate to severe or unmanageable bradycardia ( 4. Patients who are suffering from hypothyroidism for more than 10 year. 5. Patients suffering from any other systemic illness Diabetes, HTN, liver disorder, tuberculosis etc. 6. Pregnant and lactating patients. 7. Patients taking antibiotic therapy for any systemic illness within 2 months. 8. H/O of hypersensitivity of any trial drug. 9. Patient who fail to give consent. 10. Patients with genetic disorder, chronic disorder like paralysis, cancer, renal failure, hepatic failure and IHD.

Design outcomes

Primary

MeasureTime frame
Improvement in Subjective parameters 1. Weakness (Grade 0-3) 2. Dry skin (Grade 0-3) 3. Feeling cold (Grade 0-3) 4. Constipation (Grade 0-3) 5. Poor apetite (Grade 0-3) 6. Dyspnea (Grade 0-3) 7. Hoarse voice (Grade 0-3) 8. Menorrhagia (Grade 0-3) 9. Paraesthesia (Grade 0-3) 10. Weight gain (Grade 0-3)Timepoint: At baseline and at 3 months

Secondary

MeasureTime frame
Changes in Thyroid Profile i.e. T3, T4, TSH valuesTimepoint: At baseline and at 3 months

Countries

India

Contacts

Public ContactDr Sujata Yadav

Ayurvedic and Unani Tibbia College and Hospital

sujatakcdelhi@gmail.com9354925030

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026